Laparoscopic power morcellators are surgical tools with sharp edges and cutting jaws capable of creating smaller incisions than traditional surgical methods. The devices’ spinning blades break apart fibroid tissue inside the body, allowing loose fibroids to be sucked up through a small opening within the laparoscope. But according to recent studies, morcellator devices can leave cancerous tissue behind to spread to other areas of the body.
If you or a loved one underwent a hysterectomy, myomectomy, oophorectomy, or salpingectomy and developed cancer, the defective medical device lawyers atRobert DeBry & Associates want to help. With more than 200 years of combined experience, we have the legal skills and knowledge to help protect your rights. Call us 24/7 at (801) 699-9999 or complete our free initial consultation form to talk to a member of our legal staff today.
Power morcellators allow surgeons performing hysterectomies, myomectomies, and other procedures to create tiny incisions, which can allow for quicker recovery times than surgery with traditional tools. But morcellator use during uterine surgeries can spread previously undetected cancerous uterine fibroid tissue. This can significantly reduce the odds of long–term survival in women with undetected uterine sarcoma, a cancer that’s estimated to affect 1 in 350 female patients who undergo hysterectomies and myomectomies.
The tissue left behind by power morcellators can cause a variety of other severe medical conditions in the months or years that follow surgeries, such as:
The danger of using morcellators to perform laparoscopic and abdominal hysterectomies has even led some insurance companies to limit or deny coverage for the procedures. Invasive corrective surgeries are often required to treat these side effects, and in some cases the side effects may be irreversible—or even fatal.
In April 2014, the U.S. Food and Drug Administration (FDA) issued a safety communication discouraging the use of power morcellator devices in hysterectomies and myomectomies—even when specimen bags are used to help keep tissue from spreading from surgical sites:
“If laparoscopic power morcellation is performed in women with unsuspected uterine sarcoma, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis… for this reason… the FDA discourages the use of laparoscopic power morcellation during hysterectomy or myomectomy for uterine fibroids.”
In July 2014, Johnson & Johnson’s medical device unit, Ethicon, asked hospitals to return certain models of its power morcellators. The pharmaceutical giant also announced that it would suspend sales and marketing of its morcellator products while it studied safety risks cited by the FDA.
At Robert DeBry & Associates, our defective medical device attorneys want to help you get the compensation you’re owed if you or a loved one developed cancer after a power morcellator surgery. We aren’t afraid to take on powerful corporate legal teams and help you get the compensation you’re owed for your medical bills, lost wages, and pain and suffering. Don’t wait to get the legal representation you deserve.
This law firm is not associated with, sponsored by, or affiliated with the Ethicon Endo-Surgery, Inc.; Johnson & Johnson; The New York Times Company; U.S. Food and Drug Administration; or The Wall Street Journal.